Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02619487

The Impact of Mobile Technology on Clinical Outcomes in Children and Adolescents With Type 1 Diabetes

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Louisville · Academic / Other
Sex
All
Age
8 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether a simple text message reminder sent to the parent of an child/adolescent with Type 1 Diabetes(or parent and adolescent) is effective in helping the individual(or parent) become more compliant with self-managing the Type 1 Diabetes (T1D). There will be 5 arms: text message sent to parents of children age 8-12 years old with T1D, text messages sent to parents of adolescents ,age 13-18 years old, with T1D,text messages sent to parents of adolescents with T1D as well as the adolescent with T1D,no text message sent to parents of children age 8-12 years, and no text message sent to adolescents or parents of adolescents age 13-18 years old.

Detailed description

Managing Type 1 Diabetes requires daily checks of blood glucose and medication adjustments. Children and adolescents are known to have more difficulty with this than adults. Parents/legal guardians also face the task of helping with this self-management. A weekly text message regarding Type 1 Diabetes, sent to the parent or the parent and adolescent, may help to remind and motivate an individual to perform the daily tasks needed to manage their Type 1 Diabetes.

Conditions

Interventions

TypeNameDescription
OTHERtext message to parent onlyA weekly text message of an educational or motivational nature and related to Type 1 Diabetes will be sent for a duration of one year
OTHERtext message to parent and adolescentA weekly text message of an educational or motivational nature and related to Type 1 Diabetes will be sent for a duration of one year

Timeline

Start date
2019-03-01
Primary completion
2019-12-13
Completion
2019-12-13
First posted
2015-12-02
Last updated
2018-12-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02619487. Inclusion in this directory is not an endorsement.